HEADER GLYCOSYLTRANSFERASE 15-JUN-96 1PIG TITLE PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH THE OLIGOSACCHARIDE V-1532 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-AMYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ALPHA-1,4-GLUCAN-4-GLUCANOHYDROLASE; COMPND 5 EC: 3.2.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 ORGAN: PANCREAS KEYWDS ALPHA-AMYLASE ALPHA-1, 4-GLUCAN-4-GLUCANOHYDROLASE KEYWDS 2 GLYCOSYLTRANSFERASE, GLYCOSYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.MACHIUS,L.VERTESY,R.HUBER,G.WIEGAND REVDAT 8 09-AUG-23 1PIG 1 REMARK HETSYN LINK REVDAT 7 29-JUL-20 1PIG 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 25-DEC-19 1PIG 1 SEQRES REVDAT 5 20-NOV-19 1PIG 1 REMARK SEQADV LINK REVDAT 4 08-SEP-09 1PIG 1 HETATM HETNAM REVDAT 3 24-FEB-09 1PIG 1 VERSN REVDAT 2 01-APR-03 1PIG 1 JRNL REVDAT 1 07-DEC-96 1PIG 0 JRNL AUTH M.MACHIUS,L.VERTESY,R.HUBER,G.WIEGAND JRNL TITL CARBOHYDRATE AND PROTEIN-BASED INHIBITORS OF PORCINE JRNL TITL 2 PANCREATIC ALPHA-AMYLASE: STRUCTURE ANALYSIS AND COMPARISON JRNL TITL 3 OF THEIR BINDING CHARACTERISTICS. JRNL REF J.MOL.BIOL. V. 260 409 1996 JRNL REFN ISSN 0022-2836 JRNL PMID 8757803 JRNL DOI 10.1006/JMBI.1996.0410 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.WIEGAND,O.EPP,R.HUBER REMARK 1 TITL THE CRYSTAL STRUCTURE OF PORCINE PANCREATIC ALPHA-AMYLASE IN REMARK 1 TITL 2 COMPLEX WITH THE MICROBIAL INHIBITOR TENDAMISTAT REMARK 1 REF J.MOL.BIOL. V. 247 99 1995 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.QIAN,R.HASER,F.PAYAN REMARK 1 TITL CARBOHYDRATE BINDING SITES IN A PANCREATIC REMARK 1 TITL 2 ALPHA-AMYLASE-SUBSTRATE COMPLEX, DERIVED FROM X-RAY REMARK 1 TITL 3 STRUCTURE ANALYSIS AT 2.1 ANGSTROM RESOLUTION REMARK 1 REF PROTEIN SCI. V. 4 747 1995 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 3 REMARK 1 AUTH S.B.LARSON,A.GREENWOOD,D.CASCIO,J.DAY,A.MCPHERSON REMARK 1 TITL REFINED MOLECULAR STRUCTURE OF PIG PANCREATIC ALPHA-AMYLASE REMARK 1 TITL 2 AT 2.1 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 235 1560 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.QIAN,R.HASER,G.BUISSON,E.DUEE,F.PAYAN REMARK 1 TITL THE ACTIVE CENTER OF A MAMMALIAN ALPHA-AMYLASE. STRUCTURE OF REMARK 1 TITL 2 THE COMPLEX OF A PANCREATIC ALPHA-AMYLASE WITH A REMARK 1 TITL 3 CARBOHYDRATE INHIBITOR REFINED TO 2.2-A RESOLUTION REMARK 1 REF BIOCHEMISTRY V. 33 6284 1994 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 5 REMARK 1 AUTH M.QIAN,R.HASER,F.PAYAN REMARK 1 TITL STRUCTURE AND MOLECULAR MODEL REFINEMENT OF PIG PANCREATIC REMARK 1 TITL 2 ALPHA-AMYLASE AT 2.1 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 231 785 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 44944 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.500 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4366 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3904 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 125 REMARK 3 SOLVENT ATOMS : 228 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PIG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175694. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUL-95 REMARK 200 TEMPERATURE (KELVIN) : 275 REMARK 200 PH : 6.0-10.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAVATA/AGROVATA REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47260 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: 1PIF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION; 10 MICROLITER OF REMARK 280 PROTEIN (15 MG/ML IN 0.1 M AMMONIUM CACODYLATE, PH 10.0 0.001 M REMARK 280 V-1532) WERE STEPWISE CONCENTRATED OVER 0.1, 0.15, AND 0.25 M REMARK 280 AMMONIUM CACODYLATE, PH 6.0., VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 TRP A 134 CD1 CD2 NE1 CE2 CE3 CZ2 CZ3 REMARK 480 TRP A 134 CH2 REMARK 480 ASN A 350 CB CG OD1 ND2 REMARK 480 GLU A 352 CD OE1 OE2 REMARK 480 ASN A 460 CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 31 -59.22 -138.02 REMARK 500 MET A 102 -150.75 -108.07 REMARK 500 ALA A 133 -39.87 -39.74 REMARK 500 THR A 219 -7.90 -59.95 REMARK 500 ASP A 317 57.91 -111.84 REMARK 500 ASP A 402 119.39 -39.72 REMARK 500 SER A 414 -102.08 -136.01 REMARK 500 ASP A 433 31.29 -95.30 REMARK 500 SER A 437 87.91 -150.97 REMARK 500 PRO A 486 39.22 -73.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 468 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 TRESTATIN LIKE COMPOUNDS HAVE BEEN ISOLATED FROM REMARK 600 STREPTOMYCES GALBUS CULTURE MEDIUM AND TREATED WITH REMARK 600 ALPHA-AMYLASE FROM BACILLUS SUBTILIS. FROM THAT MIXTURE, REMARK 600 A SUBSTANCE WITH MOLECULAR WEIGHT 1272.5 CONTAINING TWO REMARK 600 NITROGEN ATOMS COULD BE ISOLATED. THE PRELIMINARY REMARK 600 STRUCTURE OF THIS COMPOUND HAS BEEN DETERMINED USING MASS REMARK 600 SPECTROMETRY AND FOUND TO COMPRISE 2 CYC, 2 GLA, AND 4 GLC REMARK 600 RESIDUES. THE MOLECULE SEEN IN THE ELECTRON DENSITY HAS REMARK 600 THE SEQUENCE GLA-GLC-CYC-GLA-GLC-GLC AND RESULTS FROM REMARK 600 PROCESSING OF THE ORIGINAL COMPOUND BY ALPHA-AMYLASE, A REMARK 600 PHENOMENON WHICH WAS ALREADY OBSERVED WITH ACARBOSE (SEE REMARK 600 REFERENCE 3 FOR DETAILS). REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 500 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 100 OD1 REMARK 620 2 ARG A 158 O 154.2 REMARK 620 3 ASP A 167 OD1 86.1 111.4 REMARK 620 4 ASP A 167 OD2 127.9 77.2 50.7 REMARK 620 5 HIS A 201 O 69.5 85.3 139.4 162.5 REMARK 620 6 HOH A2094 O 104.6 75.9 137.2 93.9 81.7 REMARK 620 7 HOH A2095 O 68.2 130.8 82.5 77.5 115.1 64.6 REMARK 620 8 HOH A2102 O 101.1 71.2 66.3 87.7 86.5 145.8 148.0 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AS REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTICALLY ACTIVE RESIDUES. REMARK 800 REMARK 800 SITE_IDENTIFIER: CA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: CL REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CHLORIDE BINDING SITE. DBREF 1PIG A 2 496 UNP P00690 AMYP_PIG 2 496 SEQADV 1PIG VAL A 49 UNP P00690 ILE 49 CONFLICT SEQADV 1PIG SER A 243 UNP P00690 GLN 243 CONFLICT SEQADV 1PIG SER A 310 UNP P00690 ALA 310 CONFLICT SEQADV 1PIG GLN A 404 UNP P00690 GLU 404 CONFLICT SEQADV 1PIG ASN A 451 UNP P00690 ASP 451 CONFLICT SEQADV 1PIG GLN A 484 UNP P00690 GLU 484 CONFLICT SEQRES 1 A 496 PCA TYR ALA PRO GLN THR GLN SER GLY ARG THR SER ILE SEQRES 2 A 496 VAL HIS LEU PHE GLU TRP ARG TRP VAL ASP ILE ALA LEU SEQRES 3 A 496 GLU CYS GLU ARG TYR LEU GLY PRO LYS GLY PHE GLY GLY SEQRES 4 A 496 VAL GLN VAL SER PRO PRO ASN GLU ASN VAL VAL VAL THR SEQRES 5 A 496 ASN PRO SER ARG PRO TRP TRP GLU ARG TYR GLN PRO VAL SEQRES 6 A 496 SER TYR LYS LEU CYS THR ARG SER GLY ASN GLU ASN GLU SEQRES 7 A 496 PHE ARG ASP MET VAL THR ARG CYS ASN ASN VAL GLY VAL SEQRES 8 A 496 ARG ILE TYR VAL ASP ALA VAL ILE ASN HIS MET CYS GLY SEQRES 9 A 496 SER GLY ALA ALA ALA GLY THR GLY THR THR CYS GLY SER SEQRES 10 A 496 TYR CYS ASN PRO GLY SER ARG GLU PHE PRO ALA VAL PRO SEQRES 11 A 496 TYR SER ALA TRP ASP PHE ASN ASP GLY LYS CYS LYS THR SEQRES 12 A 496 ALA SER GLY GLY ILE GLU SER TYR ASN ASP PRO TYR GLN SEQRES 13 A 496 VAL ARG ASP CYS GLN LEU VAL GLY LEU LEU ASP LEU ALA SEQRES 14 A 496 LEU GLU LYS ASP TYR VAL ARG SER MET ILE ALA ASP TYR SEQRES 15 A 496 LEU ASN LYS LEU ILE ASP ILE GLY VAL ALA GLY PHE ARG SEQRES 16 A 496 ILE ASP ALA SER LYS HIS MET TRP PRO GLY ASP ILE LYS SEQRES 17 A 496 ALA VAL LEU ASP LYS LEU HIS ASN LEU ASN THR ASN TRP SEQRES 18 A 496 PHE PRO ALA GLY SER ARG PRO PHE ILE PHE GLN GLU VAL SEQRES 19 A 496 ILE ASP LEU GLY GLY GLU ALA ILE SER SER SER GLU TYR SEQRES 20 A 496 PHE GLY ASN GLY ARG VAL THR GLU PHE LYS TYR GLY ALA SEQRES 21 A 496 LYS LEU GLY THR VAL VAL ARG LYS TRP SER GLY GLU LYS SEQRES 22 A 496 MET SER TYR LEU LYS ASN TRP GLY GLU GLY TRP GLY PHE SEQRES 23 A 496 MET PRO SER ASP ARG ALA LEU VAL PHE VAL ASP ASN HIS SEQRES 24 A 496 ASP ASN GLN ARG GLY HIS GLY ALA GLY GLY SER SER ILE SEQRES 25 A 496 LEU THR PHE TRP ASP ALA ARG LEU TYR LYS VAL ALA VAL SEQRES 26 A 496 GLY PHE MET LEU ALA HIS PRO TYR GLY PHE THR ARG VAL SEQRES 27 A 496 MET SER SER TYR ARG TRP ALA ARG ASN PHE VAL ASN GLY SEQRES 28 A 496 GLU ASP VAL ASN ASP TRP ILE GLY PRO PRO ASN ASN ASN SEQRES 29 A 496 GLY VAL ILE LYS GLU VAL THR ILE ASN ALA ASP THR THR SEQRES 30 A 496 CYS GLY ASN ASP TRP VAL CYS GLU HIS ARG TRP ARG GLU SEQRES 31 A 496 ILE ARG ASN MET VAL TRP PHE ARG ASN VAL VAL ASP GLY SEQRES 32 A 496 GLN PRO PHE ALA ASN TRP TRP ASP ASN GLY SER ASN GLN SEQRES 33 A 496 VAL ALA PHE GLY ARG GLY ASN ARG GLY PHE ILE VAL PHE SEQRES 34 A 496 ASN ASN ASP ASP TRP GLN LEU SER SER THR LEU GLN THR SEQRES 35 A 496 GLY LEU PRO GLY GLY THR TYR CYS ASN VAL ILE SER GLY SEQRES 36 A 496 ASP LYS VAL GLY ASN SER CYS THR GLY ILE LYS VAL TYR SEQRES 37 A 496 VAL SER SER ASP GLY THR ALA GLN PHE SER ILE SER ASN SEQRES 38 A 496 SER ALA GLN ASP PRO PHE ILE ALA ILE HIS ALA GLU SER SEQRES 39 A 496 LYS LEU MODRES 1PIG PCA A 1 GLN PYROGLUTAMIC ACID HET PCA A 1 8 HET GLC B 1 11 HET AGL B 2 10 HET BGC C 1 12 HET GLC C 2 11 HET AGL C 3 10 HET GLC D 1 12 HET GLC D 2 11 HET GLC E 1 12 HET BGC E 2 11 HET HMC A 703 11 HET BGC A1002 12 HET CA A 500 1 HET CL A 600 1 HETNAM PCA PYROGLUTAMIC ACID HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM AGL 4-AMINO-4,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM HMC 5-HYDROXYMETHYL-CHONDURITOL HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN AGL 4,6-DIDEOXY-4-AMINO-ALPHA-D-GLUCOSE; 4-AMINO-4-DEOXY- HETSYN 2 AGL ALPHA-D-QUINOVOPYRANOSE; 4-AMINO-4,6-DIDEOXY-ALPHA-D- HETSYN 3 AGL GLUCOSE; 4-AMINO-4,6-DIDEOXY-D-GLUCOSE; 4-AMINO-4,6- HETSYN 4 AGL DIDEOXY-GLUCOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 1 PCA C5 H7 N O3 FORMUL 2 GLC 5(C6 H12 O6) FORMUL 2 AGL 2(C6 H13 N O4) FORMUL 3 BGC 3(C6 H12 O6) FORMUL 6 HMC C7 H12 O5 FORMUL 8 CA CA 2+ FORMUL 9 CL CL 1- FORMUL 10 HOH *228(H2 O) HELIX 1 1 TRP A 21 ARG A 30 1 10 HELIX 2 2 TRP A 58 TYR A 62 5 5 HELIX 3 3 GLU A 76 VAL A 89 1 14 HELIX 4 4 PRO A 121 SER A 123 5 3 HELIX 5 5 ALA A 133 ASP A 135 5 3 HELIX 6 6 PRO A 154 ASP A 159 1 6 HELIX 7 7 ASP A 173 ILE A 189 1 17 HELIX 8 8 SER A 199 HIS A 201 5 3 HELIX 9 9 PRO A 204 LYS A 213 1 10 HELIX 10 10 SER A 244 TYR A 247 5 4 HELIX 11 11 PHE A 256 ARG A 267 1 12 HELIX 12 12 MET A 274 ASN A 279 5 6 HELIX 13 13 GLU A 282 TRP A 284 5 3 HELIX 14 14 SER A 289 ARG A 291 5 3 HELIX 15 15 ASN A 301 ARG A 303 5 3 HELIX 16 16 GLY A 309 SER A 311 5 3 HELIX 17 17 PHE A 315 ALA A 330 5 16 HELIX 18 18 GLU A 385 ARG A 387 5 3 HELIX 19 19 ARG A 389 VAL A 401 1 13 HELIX 20 20 ALA A 492 SER A 494 5 3 SHEET 1 A 6 THR A 336 SER A 340 0 SHEET 2 A 6 SER A 12 LEU A 16 1 N ILE A 13 O THR A 336 SHEET 3 A 6 GLY A 39 VAL A 42 1 N GLY A 39 O VAL A 14 SHEET 4 A 6 ARG A 92 ALA A 97 1 N ARG A 92 O VAL A 40 SHEET 5 A 6 GLY A 193 ILE A 196 1 N GLY A 193 O VAL A 95 SHEET 6 A 6 PHE A 229 GLN A 232 1 N PHE A 229 O PHE A 194 SHEET 1 B 3 GLN A 416 ARG A 421 0 SHEET 2 B 3 GLY A 425 ASN A 430 -1 N PHE A 429 O VAL A 417 SHEET 3 B 3 PHE A 487 HIS A 491 -1 N ILE A 490 O PHE A 426 SHEET 1 C 2 LEU A 436 GLN A 441 0 SHEET 2 C 2 THR A 474 ILE A 479 -1 N ILE A 479 O LEU A 436 SHEET 1 D 2 GLY A 447 CYS A 450 0 SHEET 2 D 2 LYS A 466 VAL A 469 -1 N VAL A 469 O GLY A 447 SSBOND 1 CYS A 28 CYS A 86 1555 1555 2.03 SSBOND 2 CYS A 70 CYS A 115 1555 1555 2.03 SSBOND 3 CYS A 141 CYS A 160 1555 1555 2.03 SSBOND 4 CYS A 378 CYS A 384 1555 1555 2.03 SSBOND 5 CYS A 450 CYS A 462 1555 1555 2.03 LINK C PCA A 1 N TYR A 2 1555 1555 1.33 LINK O4 HMC A 703 C1 GLC B 1 1555 1555 1.41 LINK C1 HMC A 703 N4 AGL C 3 1555 1555 1.47 LINK O4 GLC B 1 C1 AGL B 2 1555 1555 1.41 LINK O4 BGC C 1 C1 GLC C 2 1555 1555 1.40 LINK O4 GLC C 2 C1 AGL C 3 1555 1555 1.40 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.40 LINK O4 GLC E 1 C1 BGC E 2 1555 1555 1.39 LINK OD1 ASN A 100 CA CA A 500 1555 1555 2.45 LINK O ARG A 158 CA CA A 500 1555 1555 2.36 LINK OD1 ASP A 167 CA CA A 500 1555 1555 2.51 LINK OD2 ASP A 167 CA CA A 500 1555 1555 2.58 LINK O HIS A 201 CA CA A 500 1555 1555 2.41 LINK CA CA A 500 O HOH A2094 1555 1555 2.50 LINK CA CA A 500 O HOH A2095 1555 1555 2.43 LINK CA CA A 500 O HOH A2102 1555 1555 2.58 CISPEP 1 ASN A 53 PRO A 54 0 -0.30 CISPEP 2 VAL A 129 PRO A 130 0 0.04 SITE 1 AS 3 ASP A 197 GLU A 233 ASP A 300 SITE 1 CA 4 ASN A 100 ARG A 158 ASP A 167 HIS A 201 SITE 1 CL 3 ARG A 195 ASN A 298 ARG A 337 CRYST1 70.500 114.800 118.700 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014184 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008711 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008425 0.00000 HETATM 1 N PCA A 1 40.881 12.650 34.096 1.00 39.67 N HETATM 2 CA PCA A 1 40.558 13.344 35.344 1.00 35.81 C HETATM 3 CB PCA A 1 41.321 12.588 36.432 1.00 36.73 C HETATM 4 CG PCA A 1 42.510 12.105 35.629 1.00 39.27 C HETATM 5 CD PCA A 1 41.992 11.931 34.217 1.00 44.13 C HETATM 6 OE PCA A 1 42.181 11.388 33.124 1.00 50.73 O HETATM 7 C PCA A 1 40.787 14.838 35.457 1.00 33.67 C HETATM 8 O PCA A 1 40.277 15.448 36.392 1.00 33.98 O